The partnership between a Brisbane biotechnology company formed by The University of Queensland's Institute for Molecular Bioscience (IMB) and a publicly traded pharmaceutical company based on the east coast of the United States is expanding. Protagonist Therapeutics, Inc. was established ...

More »